P186D

Claim your 0.5h CE/CME Credit Here
Name*

First NameLast Name
Email*
example@example.com
What best describes your title?*

MD/DORN/NPPAPharmD/RPhRespiratory TherapistNon-Clinician Research CoordinatorOther
If MD/DO

cardiologist (interventional)cardiologist (heart failure)cardiologist (lipid/vascular)cardiologist (general)endocrinologistnephrologistemergency medicine specialistcritical care specialistpulmonologistprimary care providerindustryOther
If RN/NP

NPPICUcath labwardclinicacademicindustryOther
If PharmD

hospital/health system-basedcommunityacademicindustryOther
If PharmD, DOB

MonthDayYear
Date
If PharmD, NABP ID#
Where are you based?

EU/GBCanadaUSALatin AmericaAustralia/NZAsia
How did you FIRST hear about our tweetorials?

found it on Twitter searching in subject areafound it on twitter searching for CE/CMEfound it on Twitter by following individual influencerfound it on Twitter by following institutional influencerfrom LinkedIn
How many years have you been in practice?
How many patients do you typically see each month?
Case 1. 61 y/o F presents with a 2-day history of nausea and vomiting. PMH: HTN, endometrial cancer s/p hysterectomy in 2010, heterozygous factor II mutation. Thrombosis history includes PE in 2007, DVTs over 20 years ago. Pt takes apixaban 5 mg BID at home.

Pt diagnosed with metastases to the liver and new bilateral segmental PEs. The patient needs to be taken for a liver biopsy. How will you manage anticoagulation? The antithrombosis pharmacy consulting team was asked to weigh in.

Things to think about regarding anticoagulation: bleed risk of procedure, when to hold and resume anticoagulation surrounding procedure. Risks vs Benefits?

Anticoagulation was held pre-biopsy. The pt now is diagnosed with multiple cerebral infarcts. Will you restart anticoagulation? How?

Neurology ruled out concern for cerebral hemorrhagic conversion. The patient was given x1 dose UFH SQ 6 hours post-procedure. High-intensity UFH gtt started 12-hours post-biopsy without bolus.
1. Is this apixaban failure?*

YesNo
Case 2. 46 y/o M admitted for alcohol withdrawal to the ICU. Patient was admitted 2 weeks ago for UGIB. Thrombosis hx includes unprovoked PE in 2013.

During hospitalization, pt found to have right ulnar vein thrombosis and right basilic vein thrombosis. Should we anticoagulate this pt? The antithrombosis pharmacy consult team was asked to weigh in.

Considerations: recent GI bleed and bleed risk? Location of thrombi? Provoking factor?
2. Should we anticoagulate this pt*

YesNo
3. Did you follow the entire tweetorial?*

YesNo
4. Did you find this to be an effective learning tool?*

YesNo
5. Will you refer colleagues to similar programs from @cardiomet_CE?*

YesNo
MonthDayYear
Date
Course Title
Should be Empty: